Stevens-Johnson Syndrome: A Challenging Diagnosis

Area of Science:

• Dermatology
• Pharmacology
• Toxicology

Background:

• Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe, life-threatening mucocutaneous hypersensitivity reactions.
• These conditions are often triggered by medications, including sulfonamides, antiepileptics, and NSAIDs, and are classified as adverse cutaneous drug reactions.
• Early recognition and intervention are critical for managing SJS/TEN and improving patient outcomes.

Observation:

• A 17-year-old female presented with headache, initially diagnosed with a urinary tract infection and treated with nitrofurantoin (Macrobid).
• Her condition rapidly deteriorated over two days, necessitating emergency department visits and transfer to a burn unit.
• The patient developed severe mucocutaneous epidermal necrolysis, consistent with SJS/TEN.

Findings:

• The case illustrates a severe adverse cutaneous drug reaction potentially linked to nitrofurantoin.
• Rapid progression of symptoms highlights the aggressive nature of SJS/TEN.
• Delayed diagnosis and management contributed to the severity of the patient's condition.

Implications:

• Highlights the critical need for emergency providers to maintain a high index of suspicion for SJS/TEN.
• Emphasizes the importance of comprehensive knowledge of adverse cutaneous drug reactions for timely diagnosis and treatment.
• Underscores the potential for severe reactions to commonly prescribed medications like nitrofurantoin.